Stock Research for CYTK


Featured Broker: Ally Invest

Get the due diligence for another stock.


CYTK Stock Chart & Research Data

The CYTK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CYTK Due diligence Resources & Stock Charts

The CYTK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYTK Detailed Price Forecast - CNN Money CNN View CYTK Detailed Summary - Google Finance
Yahoo View CYTK Detailed Summary - Yahoo! Finance Zacks View CYTK Stock Research & Analysis -

Stock Analysis

TradeIdeas View CYTK Trends & Analysis - Trade-Ideas Barrons View CYTK Major Holders - Barrons
NASDAQ View CYTK Call Transcripts - NASDAQ Seeking View CYTK Breaking News & Analysis - Seeking Alpha
Spotlight View CYTK Annual Report - OTC Report View CYTK OTC Short Report -
TradeKing View CYTK Fundamentals - TradeKing Charts View CYTK SEC Filings - Bar Chart
WSJ View Historical Prices for CYTK - The WSJ Morningstar View Performance/Total Return for CYTK - Morningstar
MarketWatch View the Analyst Estimates for CYTK - MarketWatch CNBC View the Earnings History for CYTK - CNBC
StockMarketWatch View the CYTK Earnings - StockMarketWatch MacroAxis View CYTK Buy or Sell Recommendations - MacroAxis
Bullish View the CYTK Bullish Patterns - American Bulls Short Pains View CYTK Short Pain Metrics -

Social Media Mentions

StockTwits View CYTK Stock Mentions - StockTwits PennyStocks View CYTK Stock Mentions - PennyStockTweets
Twitter View CYTK Stock Mentions - Twitter Invest Hub View CYTK Investment Forum News - Investor Hub
Yahoo View CYTK Stock Mentions - Yahoo! Message Board Seeking Alpha View CYTK Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CYTK - Insider Cow View Insider Transactions for CYTK - Insider Cow
CNBC View CYTK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYTK - OTC Markets
Yahoo View Insider Transactions for CYTK - Yahoo! Finance NASDAQ View Institutional Holdings for CYTK - NASDAQ

Stock Charts

FinViz View CYTK Stock Insight & Charts - StockCharts View CYTK Investment Charts -
BarChart View CYTK Stock Overview & Charts - BarChart Trading View View CYTK User Generated Charts - Trading View

Latest Financial News for CYTK

Cantor Fitzgerald's 7 Buys For 7 Biotechs
Posted on Friday September 21, 2018

Cantor Fitzgerald has high hopes for patients with rare and orphan diseases.  “We believe that biotech has entered a golden age of innovation and productivity across many therapeutic areas,” the firm said ...

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Posted on Sunday September 16, 2018

Biotech were trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction ...

Cytokinetics to Present at the Morgan Stanley Global Healthcare Conference
Posted on Wednesday September 05, 2018

Cytokinetics, Inc. (CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the 16th Annual Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018 at 11:40 AM ET at the Grant Hyatt in New York City. The webcast replay of the presentation will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of the event. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.

Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter
Posted on Tuesday August 28, 2018

Cytokinetics, Incorporated (CYTK) today announced that The ALS Association Golden West Chapter is the inaugural recipient of the Cytokinetics Communications Fellowship, an annual grant from the company intended to support increased capacity and community engagement for nonprofit organizations. “As a longstanding partner of the disease and patient advocacy community, we recognized a need for organizations to expand the scope of their communications to support families with rare diseases of muscle dysfunction and we sought an opportunity to close that gap,” said Diane Weiser, Cytokinetics’ Vice President of Corporate Communications and Investor Relations. “We are extremely grateful to Cytokinetics and honored to receive this unique grant,” said Fred Fisher, MSW, President and CEO of The ALS Association Golden West Chapter.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.